Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADCETRIS Cause Progressive multifocal leukoencephalopathy? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Progressive multifocal leukoencephalopathy have been filed in association with ADCETRIS. This represents 4.8% of all adverse event reports for ADCETRIS.

5
Reports of Progressive multifocal leukoencephalopathy with ADCETRIS
4.8%
of all ADCETRIS reports
3
Deaths
4
Hospitalizations

How Dangerous Is Progressive multifocal leukoencephalopathy From ADCETRIS?

Of the 5 reports, 3 (60.0%) resulted in death, 4 (80.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.

Is Progressive multifocal leukoencephalopathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADCETRIS. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ADCETRIS Cause?

Off label use (9) Death (8) Pleural effusion (7) Infusion related reaction (6) Pancreatitis (6) Pyrexia (6) Rash (6) Anaphylactic reaction (5) Hodgkin's disease (5) Neuropathy peripheral (5)

What Other Drugs Cause Progressive multifocal leukoencephalopathy?

NATALIZUMAB (1,668) RITUXIMAB (1,647) CYCLOPHOSPHAMIDE (782) PREDNISONE (606) PREDNISOLONE (439) TACROLIMUS (438) METHOTREXATE (428) DOXORUBICIN (421) MYCOPHENOLATE MOFETIL (414) VINCRISTINE (376)

Which ADCETRIS Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?

ADCETRIS vs ADDERALL ADCETRIS vs ADEFOVIR ADCETRIS vs ADEFOVIR DIPIVOXIL ADCETRIS vs ADEMETIONINE ADCETRIS vs ADENOSINE

Related Pages

ADCETRIS Full Profile All Progressive multifocal leukoencephalopathy Reports All Drugs Causing Progressive multifocal leukoencephalopathy ADCETRIS Demographics